{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:45:04Z","timestamp":1790876704808,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T00:00:00Z","timestamp":1702339200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.nbd.2023.106379","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:10:52Z","timestamp":1702653052000},"page":"106379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease"],"prefix":"10.1016","volume":"190","author":[{"given":"Keke","family":"Liang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingge","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zonghan","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongsheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2023.106379_bb0005","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41572-021-00280-3","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.nbd.2023.106379_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/jnc.14450","article-title":"High-mobility group box 1 in Parkinson\u2019s disease: from pathogenesis to therapeutic approaches","volume":"146","author":"Angelopoulou","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2023.106379_bb0015","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1093\/brain\/awp068","article-title":"The retina in Parkinson\u2019s disease","volume":"132","author":"Archibald","year":"2009","journal-title":"Brain."},{"key":"10.1016\/j.nbd.2023.106379_bb0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/labinvest.2008.165","article-title":"Intraocular expression and release of high-mobility group box 1 protein in retinal detachment","volume":"89","author":"Arimura","year":"2009","journal-title":"Lab. Investig."},{"key":"10.1016\/j.nbd.2023.106379_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/opo.12009","article-title":"Statistical guidelines for the analysis of data obtained from one or both eyes","volume":"33","author":"Armstrong","year":"2013","journal-title":"Ophthalmic Physiol. Opt."},{"key":"10.1016\/j.nbd.2023.106379_bb0030","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1212\/WNL.0000000000012125","article-title":"APOSTEL 2.0 recommendations for reporting quantitative optical coherence tomography studies","volume":"97","author":"Aytulun","year":"2021","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106379_bb0035","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2023.106379_bb0040","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.expneurol.2007.05.022","article-title":"Cell systems and the toxic mechanism(s) of alpha-synuclein","volume":"209","author":"Cookson","year":"2008","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0045","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.bbi.2008.05.007","article-title":"Malaise in the water maze: untangling the effects of LPS and IL-1beta on learning and memory","volume":"22","author":"Cunningham","year":"2008","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.nbd.2023.106379_bb0050","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106379_bb0055","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1212\/WNL.0b013e3181fc29c9","article-title":"The MoCA: well-suited screen for cognitive impairment in Parkinson disease","volume":"75","author":"Dalrymple-Alford","year":"2010","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106379_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.nbd.2023.106379_bb0065","article-title":"Macular structure and microvasculature changes in AIDS-related cytomegalovirus retinitis using optical coherence tomography angiography","volume":"8","author":"Du","year":"2021","journal-title":"Front. Med. (Lausanne)."},{"key":"10.1016\/j.nbd.2023.106379_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.parkreldis.2017.02.014","article-title":"Ocular and visual disorders in Parkinson\u2019s disease: common but frequently overlooked","volume":"40","author":"Ekker","year":"2017","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0075","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00415-019-09197-0","article-title":"Subjective cognitive decline and progression to dementia in Parkinson\u2019s disease: a long-term follow-up study","volume":"266","author":"Galtier","year":"2019","journal-title":"J. Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0080","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Movem. Disord.\u202f: Off. J. Movement Disorder Society."},{"key":"10.1016\/j.nbd.2023.106379_bb0085","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/s41586-023-06373-1","article-title":"cGAS-STING drives ageing-related inflammation and neurodegeneration","volume":"620","author":"Gulen","year":"2023","journal-title":"Nature."},{"key":"10.1016\/j.nbd.2023.106379_bb0090","first-page":"2473","article-title":"Decreased dopamine in the retinas of patients with Parkinson\u2019s disease","volume":"31","author":"Harnois","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.nbd.2023.106379_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114146","article-title":"High-mobility group box 1-mediated hippocampal microglial activation induces cognitive impairment in mice with neuropathic pain","volume":"355","author":"Hisaoka-Nakashima","year":"2022","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0100","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/mds.27002","article-title":"Mild cognitive impairment as a risk factor for Parkinson\u2019s disease dementia","volume":"32","author":"Hoogland","year":"2017","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fnmol.2017.00013","article-title":"HMGB1 mediates autophagy dysfunction via perturbing Beclin1-Vps34 complex in dopaminergic cell model","volume":"10","author":"Huang","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.nbd.2023.106379_bb0110","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","article-title":"Parkinson\u2019s disease","volume":"386","author":"Kalia","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.nbd.2023.106379_bb0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/WNO.0000000000000240","article-title":"Correlation between structural and functional retinal changes in Parkinson disease","volume":"35","author":"Kaur","year":"2015","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.nbd.2023.106379_bb0120","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1099-1166(200007)15:7<644::AID-GPS167>3.0.CO;2-L","article-title":"The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson\u2019s disease","volume":"15","author":"Leentjens","year":"2000","journal-title":"Int. J. Geriatr. Psychiat."},{"key":"10.1016\/j.nbd.2023.106379_bb0125","first-page":"2735","article-title":"Alpha-Synuclein filaments bind the transcriptional regulator HMGB-1","volume":"15","author":"Lindersson","year":"2004","journal-title":"Neuroreport."},{"key":"10.1016\/j.nbd.2023.106379_bb0130","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson\u2019s disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0135","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0165-0327(88)90072-9","article-title":"The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders","volume":"14","author":"Maier","year":"1988","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0140","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.expneurol.2011.08.012","article-title":"High-mobility group box-1 impairs memory in mice through both toll-like receptor 4 and receptor for advanced glycation end products","volume":"232","author":"Mazarati","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1136\/bjo.82.8.971","article-title":"People and eyes: statistical approaches in ophthalmology","volume":"82","author":"Murdoch","year":"1998","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.nbd.2023.106379_bb0150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/ana.25944","article-title":"Retinal thickness predicts the risk of cognitive decline in Parkinson disease","volume":"89","author":"Murueta-Goyena","year":"2021","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0155","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122650","article-title":"High mobility group Box-1 and blood-brain barrier disruption","volume":"9","author":"Nishibori","year":"2020","journal-title":"Cells."},{"key":"10.1016\/j.nbd.2023.106379_bb0160","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2104689118","article-title":"Dietary \u03c9-3 polyunsaturated fatty acids are protective for myopia","volume":"118","author":"Pan","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2023.106379_bb0165","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0170","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","article-title":"In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson\u2019s disease which can be attenuated by glycyrrhizin","volume":"91","author":"Santoro","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2023.106379_bb0175","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/WNO.0000000000000203","article-title":"Ganglion cell-inner plexiform layer thickness in patients with Parkinson disease and association with disease severity and duration","volume":"35","author":"Sari","year":"2015","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.nbd.2023.106379_bb0180","doi-asserted-by":"crossref","first-page":"11832","DOI":"10.1038\/s41598-019-48388-7","article-title":"Inner retinal thinning as a biomarker for cognitive impairment in de novo Parkinson\u2019s disease","volume":"9","author":"Sung","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2023.106379_bb0185","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson's disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2023.106379_bb0190","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2023.106379_bb0195","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084107","article-title":"A monoclonal anti-HMGB1 antibody attenuates neurodegeneration in an experimental animal model of Glaucoma","volume":"23","author":"Tonner","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2023.106379_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100157","article-title":"Association of Inner Retinal Thickness with prevalent dementia and brain atrophy in a general older population: the Hisayama study","volume":"2","author":"Ueda","year":"2022","journal-title":"Ophthalmol. Sci."},{"key":"10.1016\/j.nbd.2023.106379_bb0205","doi-asserted-by":"crossref","first-page":"e1581","DOI":"10.1212\/WNL.0000000000207727","article-title":"Retinal optical coherence tomography features associated with incident and prevalent Parkinson disease","volume":"101","author":"Wagner","year":"2023","journal-title":"Neurology."},{"key":"10.1016\/j.nbd.2023.106379_bb0210","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbadis.2008.09.009","article-title":"Targets for neuroprotection in Parkinson\u2019s disease","volume":"1792","author":"Yacoubian","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2023.106379_bb0215","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1080\/02713683.2021.1933054","article-title":"Retinal flow density changes in early-stage Parkinson\u2019s disease investigated by swept-source optical coherence tomography angiography","volume":"46","author":"Zhang","year":"2021","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.nbd.2023.106379_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.762394","article-title":"Appearance of tumor vessels in patients with choroidal osteoma using swept-source optical coherence tomographic angiography","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996123003959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:40:23Z","timestamp":1760852423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996123003959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":44,"alternative-id":["S0969996123003959"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106379","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2023.106379","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106379"}}